Nike names Pfizer CFO David Denton as finance chief, replacing Matthew Friend

NIKE, Inc. Class B
Pfizer Inc.

NIKE, Inc. Class B

NKE

0.00

Pfizer Inc.

PFE

0.00
  • Nike named David M. Denton executive vice president and CFO, effective Aug. 17; Matthew Friend will step down and stay through Sept. 4.
  • Friend will participate in the fiscal 2026 fourth-quarter earnings call on June 30.
  • Denton joins from Pfizer, where he has served as CFO and executive vice president since May 2022.
  • He previously held CFO roles at Lowe’s from 2018 to 2022 and at CVS Health earlier in his career.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nike Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260623328558) on June 23, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.